4882.T JPX
Perseus Proteomics Inc.
1W: -5.8%
1M: +11.8%
3M: +1.3%
YTD: -32.4%
1Y: -60.3%
3Y: -42.3%
5Y: -79.9%
¥166.00 ($1.05)
+5.00 (+3.11%)
Weekly Expected Move ±7.8%
¥136
¥148
¥161
¥174
¥186
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Cash Flow Trends
Operating Cash Flow
-$719M
+13.7% ▲
Capital Expenditures
$75M
+52.7% ▲
5Y CAGR: +95.9%
Free Cash Flow
-$795M
+20.0% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$4M
-4393.8% ▼
Net Change in Cash
$127M
+114.0% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$411M | -$597M | -$785M | -$1.1B | -$905M |
| Depreciation & Amort. | $55K | $3M | $6M | $3M | $3M |
| Stock-Based Comp. | $0 | $0 | $31M | $41M | $0 |
| Change in Working Capital | -$11M | -$16M | $90M | $109M | $99M |
| Other Non-Cash Items | -$696K | $133M | $94M | $117M | $84M |
| Operating Cash Flow | -$423M | -$477M | -$564M | -$834M | -$719M |
| — Investing Activities — | |||||
| Capital Expenditures | -$3M | -$34M | -$171M | -$159M | -$75M |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | -$42M | $9M | $0 |
| Investing Cash Flow | -$3M | -$34M | -$213M | -$150M | -$75M |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $0 | $0 | $0 |
| Stock Repurchased | $0 | $0 | -$20K | -$97K | -$4M |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $3M | -$5M | $0 | $565K | -$1K |
| Financing Cash Flow | $1.0B | $2.6B | -$20K | $64M | $923M |
| Net Change in Cash | $587M | $2.1B | -$770M | -$904M | $127M |
| Cash End of Period | $1.1B | $3.2B | $2.4B | $1.5B | $1.7B |
| Free Cash Flow | -$426M | -$511M | -$735M | -$993M | -$795M |